Molecular dynamics simulations of the first steps of the reaction catalyzed by HIV-1 protease

Biophysical Journal

Volumn 83, Issue 2, 2002, Pages 794-807

  Trylska, Joanna ^a   Bała, Piotr ^a,b   Geller, Maciej ^a,c   Grochowski, Pawel ^a  

^a UNIVERSITY OF WARSAW   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; PROTEINASE; NITROGEN; PROTON; WATER;

ARTICLE; CALCULATION; CATALYSIS; CHEMICAL BOND; CONFORMATION; ENZYME ACTIVE SITE; ENZYME MECHANISM; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROGEN BOND; MOLECULAR DYNAMICS; NONHUMAN; PROTON TRANSPORT; SIMULATION; BINDING SITE; BIOPHYSICS; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; ENZYME SPECIFICITY; METABOLISM; PH; PROTEIN BINDING; PROTEIN CONFORMATION; TIME;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ASPARTIC ACID; BINDING SITES; BIOPHYSICS; CATALYSIS; HIV PROTEASE; HYDROGEN BONDING; HYDROGEN-ION CONCENTRATION; MODELS, CHEMICAL; MODELS, MOLECULAR; NITROGEN; PROTEIN BINDING; PROTEIN CONFORMATION; PROTONS; SUBSTRATE SPECIFICITY; TIME FACTORS; WATER;

EID: 0035997007     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(02)75209-0     Document Type: Article

References (53)

1. Computing the ionization states of proteins with a detailed charge model
2. Prediction of pH-dependent properties of proteins
3. as in proteins
4. 2
5. 2
6. Density functional termochemistry: III. The role of exact exchange
7. Tunneling and zero-point motion in high pressure ice
8. Treatment of long-range forces in molecular dynamics
9. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations
10. Polar hydrogen positions in proteins: Empirical energy placement and neutron diffraction comparison
11. HIV-1 protease cleavage mechanism elucidated with molecular dynamics simulation
12. HIV-1 protease cleavage mechanism: A theoretical investigation based on classical MD simulation and reaction path calculations using a hybrid QM/MM potential
13. Electrostatics and diffusion of molecules in solution: Simulations with the University of Houston Brownian Dynamics Program
14. Enzyme mechanisms with hybrid quantum and molecular mechanical potentials: I. Theoretical considerations
15. Simulating enzyme reactions: Challenges and perspectives
16. Analysis of the structure of HIV-1 protease complexed with a hexapeptide inhibitor: Part II: Molecular dynamics studies of the active site region
17. Density functional based parametrization of a valence bond method and its applications in quantum-classical molecular dynamics simulations of enzymatic reactions
18. Prediction of the protonation state of the active site aspartyl residues in HIV-1 protease-inhibitor complexes via molecular dynamics simulation
19. Domain communication in the dynamical structure of human immunodeficiency virus I protease
20. Human immunodeficiency virus-1 protease: II. Use of pH rate studies and solvent kinetic isotope effects to elucidate details of chemical mechanism
21. 18O isotope exchange
22. Kinetic studies of human immunodeficiency virus type 1 protease and its active-site hydrogen bond mutant A28S
23. Flap opening and dimer-interface flexibility in the free and inhibitor-bound HIV protease, and their implications for function
24. Active human immunodeficiency virus protease is required for viral infectivity
25. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density
26. An ab initio quantum mechanical model for the catalytic mechanism of HIV-1 protease
27. A combined quantum/classical molecular dynamics study of the catalytic mechanism of HIV protease
28. Electrostatics and diffusion of molecules in solution: Simulations with the University of Houston Brownian Dynamics program
29. Analysis of the structure of chemically synthesized HIV-1 protease complexed with a hexapeptide inhibitor: Part I: Crystallographic refinement of 2 Angstrom data
30. Ab initio studies on the catalytic mechanism of aspartic proteinases: Nucleophilic versus general acid/general base mechanism
31. Conformational flexibility of the catalytic asp dyad in HIV-1 protease: An ab initio study on the free enzyme
32. Ab initio molecular dynamics based assignment of the protonation state of pepstatin A/HIV-1 protease cleavage site
33. Use of nitrogen-15 kinetic isotope effects to elucidate details of the chemical mechanism of human immunodeficiency virus 1 protease
34. The GROMOS biomolecular simulation program package
35. Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance
36. Inhibition and catalytic mechanism of HIV-1 aspartic protease
37. Consistent dielectric properties of the simple point charge and extended simple point charge water models at 277 and 300K
38. Ionization states of the catalytic residues in HIV-1 protease
39. Investigation of domain structure in proteins via molecular dynamics simulation: Application to HIV-1 protease dimer
40. Monte Carlo free energy estimates using non-Boltzmann sampling: Application to the sub-critical Lennard-Jones fluid
41. Thermodynamic linkage between the binding of protons and inhibitors to HIV-1 protease
42. Parameterization of the approximate valence bond (AVB) method to describe potential energy surface in the reaction catalyzed by HIV-1 protease
43. On the quantum nature of the shared proton in hydrogen bonds
44. The elucidation of enzymatic reaction mechanisms by computer simulation: Human immunodeficiency virus protease catalysis
45. Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272
46. An empirical valence bond approach for comparing reactions in solutions and in enzymes
47. Molecular dynamics simulations of HIV-1 protease with peptide substrate
48. Conserved folding in retrovirial proteases: Crystal structure of a synthetic HIV-1 protease
49. NMR and X-ray evidence that the HIV protease catalytic aspartyl groups are protonated in the complex formed by the protease and a non-peptide cyclic urea-based inhibitor